| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |